Stock Chart

INMD

$14.03 -0.78%
Score: 50.1 HOLD
LEAPs: SELL $15
i
LEAPs Option Signal

Type: SELL growth_1yr
Strike: $15
Premium: $2.65
Expiry: Jan 15, 2027
Target: $13
Score: -100

LEAPs are long-term options (1+ year) with less time decay.
Pro
Screener
Vol: 1.00x (vs SPY: 1.3x | vs QQQ: 1.1x)
Volume Ratio Explained

Vol: Current volume vs 20-day average
vs SPY: Relative activity vs market
vs QQQ: Relative activity vs tech

Color Guide:
● Red (≥1.5x): High activity
● Yellow (≥1.2x): Above average
● Blue (≤0.7x): Low activity

Interpretation:
• vs SPY > 1: Stock-specific interest
• vs SPY < 1: Stock quiet vs market
Chart Pattern · as of Oct 21, 2026
Falling Channel Bullish scenario quality 66/100
Measured-move target $14.33 (+2.2%)
Historically breaks up 64% of the time; target hit in 60% of up-breaks (n=559)
Pattern detection is automated and probabilistic — a scenario map for levels, not a buy/sell signal. Rails, projected path and target are drawn on the chart below.
Technical Chart
CHART OVERLAYS
Active: 2
INDICATORS
TRENDLINES
OPTIONS FLOW
VOLUME & PRICE
OTHER

About INMD - InMode Ltd. Ordinary Shares

InMode Ltd provides minimally and non-invasive surgical aesthetic and medical treatment solutions in the United States. Its products and solutions address three energy-based treatment categories that include face & body contouring, medical aesthetics, and women's health. InMode has developed products using its technology for plastic surgery, dermatology, gynecology, and ophthalmology. Its product platforms include BodyTite, Optimas, Votiva, Contoura, Triton, EmbraceRF, EvolveX, Evoke, EmpowerRF and Morpheus8. The majority of its revenue comes from the United States.

Key Statistics

Market Cap $814M
P/E Ratio 11.59

This INMD stock chart provides comprehensive technical analysis including candlestick patterns, volume profile analysis, and options open interest data. Track INMD's price movements with trendlines, gamma walls, and key support/resistance levels.